SK Chemicals announced the approval for its tetravalent vaccine with the cell cultivation system is drawing near

The SK Chemicals’ tetravalent influenza vaccine, having the cell cultivation system, is expected to acquire an approval soon.

On the 1^st, Hoon Kim, Vaccine R&D Director of SK Chemicals, announced at the ‘Global Bio Conference 2015,’ held at Songdo Convensia, that it has turned in an approval to the Ministry of Food and Drug Safety after completing clinical trials for its tetravalent vaccine.